LightHearted AI
LightHearted AI is a London-based medical device company founded in 2023 that builds LightScope, a laser- and ultrafast-camera-based non-contact cardiac scanner using AI analytics to detect valvular and vascular conditions, currently in clinical trial with NHS Dorset.
- Company typePrivate
- Founded2023
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What LightHearted AI does
LightHearted AI is a London-based medical device company founded in 2023 that develops LightScope, a photonics-based cardiac detection system. The device uses laser illumination and ultrafast cameras to capture high-fidelity hemodynamic data from the neck without physical contact in approximately 10 seconds, with the company claiming 16× higher signal-to-noise ratio than conventional stethoscopes. Automated AI analytics process this data to detect valvular and vascular conditions, with particular emphasis on addressing a documented gender-based diagnostic gap in cardiovascular disease.
The company operates an enterprise field sales model targeting NHS hospitals and healthcare systems, with a 'Request a demo' call-to-action on its website. Its revenue model is expected to combine hardware sales of the LightScope device with a recurring AI software/subscription component delivered through the LightScope AI Platform, which supports multi-device (desktop and mobile) viewing for clinical workflow integration. As of available data, LightHearted AI remains in the clinical trial phase, with an active deployment at NHS Dorset evaluating the device for early cardiovascular disease diagnosis. The company has 1–10 employees, was selected for Intel Ignite's Spring 2024 UK cohort, and has received media coverage from Forbes, MassDevice, and other industry publications.
LightHearted AI firmographics
Firmographics- Name
- LightHearted AI
- Legal name
- LightHearted AI
- Website
- https://lighthearted.ai
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- LightHearted AI is a London-based medical device company founded in 2023 that builds LightScope, a laser- and ultrafast-camera-based non-contact cardiac scanner using AI analytics to detect valvular and vascular conditions, currently in clinical trial with NHS Dorset.
- Ownership category
- akta.pro rank
LightHearted AI industry classification
Industry- Product category
- Cardiac Diagnostics Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Portable, Mobile & Point-of-Care Imaging Systems (HLAHABAL)
- akta.pro secondary industries
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Edge-Based Clinical Decision Support & Alerts (On-Device/On-Prem Analytics) (HLACAPAL)
Keywords
Where LightHearted AI is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
LightHearted AI business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Medical Device Sales: Sale of LightScope hardware devices to healthcare providers including NHS hospitals and healthcare systems. The device is being trialed with NHS Dorset to demonstrate clinical value before wider procurement.
- AI Software/Subscription: Automated AI analytics platform likely operates on a subscription or software licensing model integrated with the LightScope device hardware.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
LightHearted AI product offering
Product offeringCore offering
LightHearted AI develops and sells the LightScope system, a photonics-based medical device that uses laser technology and ultrafast cameras to capture high-fidelity hemodynamic data from the neck via a 10-second non-contact scan. The bundled LightScope AI Platform automatically analyses this data to detect valvular and vascular cardiac conditions within seconds. The offering targets hospitals, clinicians, and healthcare systems as a point-of-care alternative to stethoscope-based auscultation.
Product overview
LightHearted AI offers a unified point-of-care cardiac detection system consisting of two integrated components: the LightScope Device (a laser-based non-contact cardiac scanner) and the LightScope AI Platform (software providing automated analytics and multi-device compatibility). The device captures hemodynamic data via ultrafast cameras in 10-second neck scans, while the platform processes this data to detect valvular and vascular conditions automatically. The system is designed for use during routine vitals by medical assistants, with a focus on addressing diagnostic gaps in women's cardiac health.
Differentiator
Problem solved
Functional benefit
Brands
- LightScope: AI-powered cardiac detection device using photonics technology with 16× signal clarity, 10-second non-contact scanning, and automated analytics for valvular and vascular condition detection.
- LightScope AI Platform
Products and services
- LightScope Device A medical device using laser and ultrafast camera technology to capture high-fidelity hemodynamic data from the neck non-contact within 10 seconds. Delivers 16x higher signal-to-noise ratio than stethoscopes and detects valvular and vascular heart conditions automatically via AI. Designed for use by medical assistants during routine vitals in clinical settings.
- LightScope AI Platform Software platform providing automated AI analytics for cardiac condition detection. Built for interoperability and ease of use, with multi-device (desktop and mobile) applications for viewing diagnostic results and clinical workflow integration.
Quantifiable outcome
- 16× higher signal-to-noise ratio than stethoscopes
- +3 more outcomes
Companies that use LightHearted AI
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
LightHearted AI technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature6 records
LightHearted AI partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Intel IgnitecoreLightHearted AI was selected for Intel Ignite's Spring 2024 UK cohort from 200 applicants. Intel Ignite is Intel's startup acceleration program that provides mentorship, resources, and ecosystem support for early-stage technology companies working on AI, energy efficiency, and data technology.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
LightHearted AI competitors and assessment
Company assessmentDirect peers
- Eko Health: Eko Health sells FDA-cleared AI-enabled digital stethoscopes (CORE 500) and ECG devices that automate cardiac and pulmonary analysis at the point of care — the same workflow LightScope targets, but using acoustic + ECG signals rather than photonics.
- AliveCor: AliveCor's KardiaMobile 6L is a pocket-sized AI-ECG device that detects arrhythmias and other cardiac conditions for clinicians and consumers; it competes directly with LightScope for the same automated, point-of-care cardiac detection workflow.
- Ultromics: Ultromics applies AI to echocardiography for automated detection of cardiac amyloidosis, HFpEF, and other conditions. It targets the same AI-driven cardiac diagnostics market as LightScope, with FDA-cleared products already in clinical use.
Emerging players
- StethoMe: StethoMe develops AI-powered electronic stethoscopes for remote lung and heart sound analysis, focusing on home and pediatric use cases. It overlaps with LightScope's automated cardiac auscultation value proposition but uses acoustic rather than photonic capture.
- Butterfly Network: Butterfly Network's handheld, AI-enabled ultrasound probe (iQ3) brings point-of-care cardiac imaging to non-specialists. It competes with LightScope for the same clinician workflow of rapid, AI-augmented cardiac assessment at the bedside.
- Cleerly: Cleerly applies AI to cardiac CT angiography to characterize coronary plaque and predict cardiovascular events. Like LightHearted AI, it targets earlier, more accurate cardiovascular disease detection, but via imaging rather than hemodynamics.
Broad incumbents
- HeartFlow: HeartFlow is a leading AI cardiac imaging company using CT-derived FFR analysis to non-invasively detect coronary artery disease. It is a broader cardiac-AI-imaging incumbent that competes for the same cardiology budget and clinical mindshare as LightScope.
- GE HealthCare: GE HealthCare is a dominant provider of cardiac imaging and monitoring equipment (ultrasound, ECG, patient monitors) sold into the same hospital and NHS procurement channels that LightHearted AI is targeting with LightScope.
- Philips: Philips is a global incumbent in cardiac ultrasound, patient monitoring, and cardiology informatics, with established NHS and hospital relationships. It is the broad incumbent that LightHearted AI must displace or partner with to scale.
Others
- 3M Littmann: 3M Littmann is the dominant incumbent in stethoscope-based cardiac auscultation. LightHearted AI explicitly positions LightScope as a potential stethoscope replacement, making Littmann the canonical workflow incumbent being displaced.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
LightHearted AI social profiles
Digital presenceLightHearted AI financial estimates
Financial estimateRevenue estimate
Valuation estimate
LightHearted AI leadership team
Management profileNumber of profiles
LightHearted AI funding detail
Funding detailFunding overview
Funding rounds2 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LightHearted AI M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LightHearted AI
What does LightHearted AI do?
LightHearted AI develops and sells the LightScope system, a photonics-based medical device that uses laser technology and ultrafast cameras to capture high-fidelity hemodynamic data from the neck via a 10-second non-contact scan. The bundled LightScope AI Platform automatically analyses this data to detect valvular and vascular cardiac conditions within seconds. The offering targets hospitals, clinicians, and healthcare systems as a point-of-care alternative to stethoscope-based auscultation.
Is LightHearted AI a public or private company?
LightHearted AI is a private company. It is classified as venture growth investor backed and is currently operating.
When was LightHearted AI founded?
LightHearted AI was founded in 2023. It employs 1 to 10 people.
Where is LightHearted AI based?
LightHearted AI is headquartered in London, United Kingdom, in the Europe region.
How does LightHearted AI make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are AI Software/Subscription.
Who are LightHearted AI's main competitors?
Direct peers on record are Eko Health, AliveCor and Ultromics. Emerging players are StethoMe, Butterfly Network and Cleerly. Broad incumbents are HeartFlow, GE HealthCare and Philips. 3M Littmann is listed as an others.
Does LightHearted AI have an API?
No public API is recorded for LightHearted AI.
What industry is LightHearted AI in?
LightHearted AI's product category is Cardiac Diagnostics Medical Devices. Its primary akta.pro industry code is HLAHABAL, Portable, Mobile & Point-of-Care Imaging Systems, with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 334510 and its SIC code is 3841.